1 INTRODUCTION (Page No. – 19)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKET SCOPE
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 23)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 30)

4 PREMIUM INSIGHTS (Page No. – 33)
4.1 WOUND DRESSINGS MARKET OVERVIEW
4.2 WOUND DRESSINGS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
4.3 WOUND DRESSINGS MARKET SHARE, BY END USER, 2020 VS. 2025
4.4 WOUND DRESSINGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW (Page No. – 36)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of chronic diseases & conditions affecting wound healing capabilities
5.2.1.2 Increasing spending on chronic and surgical wounds
5.2.1.3 Increasing number of road accidents and trauma injuries
5.2.1.4 Technological advancements in wound dressings
5.2.1.5 High rate of cesarean sections in elderly mothers
5.2.2 RESTRAINTS
5.2.2.1 High cost of advanced wound dressings
5.2.2.2 Risks associated with the use of wound dressings
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential in emerging economies
5.2.4 TRENDS
5.2.4.1 Acquisitions by leading companies in the market
5.2.4.2 Focus on expanding capabilities of current technologies and launching novel products
5.2.4.2.1 Smart wound dressings
5.2.4.2.2 Crab shell bandages
5.2.4.2.3 Color changing dressings
5.2.4.2.4 Integration of nanotechnology in wound dressings
5.2.5 CHALLENGES
5.2.5.1 Competitive pricing pressure
5.3 COVID-19 IMPACT ON THE WOUND DRESSINGS MARKET

6 WOUND DRESSINGS MARKET, BY TYPE (Page No. – 47)
6.1 INTRODUCTION
6.2 ADVANCED WOUND DRESSINGS
6.2.1 FOAM DRESSINGS
6.2.1.1 Foam dressings are used for a large variety of wounds
6.2.1.2 Silicone foam dressings
6.2.1.3 Non-silicone foam dressings
6.2.2 HYDROCOLLOID DRESSINGS
6.2.2.1 Hydrocolloid dressings are cost-effective
6.2.3 FILM DRESSINGS
6.2.3.1 Due to their non-absorbable nature, film dressings are not used for treating exuding wounds, which could limit their adoption to a certain extent
6.2.4 ALGINATE DRESSINGS
6.2.4.1 Alginate dressings are well-suited for pressure and diabetic foot ulcers
6.2.5 HYDROGEL DRESSINGS
6.2.5.1 Hydrogel dressings are available in several forms for effective use
6.2.6 COLLAGEN DRESSINGS
6.2.6.1 Favorable reimbursement scenario for collagen dressings is supporting the growth of this segment
6.2.7 HYDROFIBER DRESSINGS
6.2.7.1 Hydrofiber dressings combine the properties of hydrocolloids and alginates
6.2.8 WOUND CONTACT LAYERS
6.2.8.1 Wound contact layers protect wound beds from bacterial and fungal growth
6.2.9 SUPERABSORBENT DRESSINGS
6.2.9.1 Superabsorbent dressings are used where adhesive dressings may cause damage
6.2.10 OTHER ADVANCED DRESSINGS
6.3 TRADITIONAL WOUND DRESSINGS
6.3.1 PRESENCE OF A LARGE PATIENT POPULATION FOR PRESSURE ULCERS HAS ENSURED A SUSTAINED DEMAND FOR THESE DRESSINGS

7 WOUND DRESSINGS MARKET, BY WOUND TYPE (Page No. – 61)
7.1 INTRODUCTION
7.2 SURGICAL & TRAUMATIC WOUNDS
7.2.1 GROWING VOLUME OF SURGICAL PROCEDURES PERFORMED & INCREASING INCIDENCE OF BURN INJURIES TO SUPPORT MARKET GROWTH
7.3 DIABETIC FOOT ULCERS
7.3.1 INCREASING PREVALENCE OF DIABETES TO PROPEL MARKET GROWTH
7.4 PRESSURE ULCERS
7.4.1 THE PREVALENCE OF PRESSURE ULCERS INCREASES WITH AGE
7.5 VENOUS LEG ULCERS
7.5.1 RISING GERIATRIC POPULATION IS SUPPORTING THE GROWTH OF THIS SEGMENT
7.6 BURNS & OTHER WOUNDS
7.6.1 THE INCIDENCE OF BURN INJURIES IS HIGH IN EMERGING COUNTRIES

8 WOUND DRESSINGS MARKET, BY END USER (Page No. – 68)
8.1 INTRODUCTION
8.2 HOSPITALS, ASCS, AND CLINICS
8.2.1 GROWING NUMBER OF HOSPITAL READMISSIONS IS SUPPORTING THE GROWTH OF THIS SEGMENT
8.3 HOME CARE SETTINGS
8.3.1 NEED TO CONTROL THE RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH
8.4 OTHER END USERS

9 WOUND DRESSING MARKET, BY REGION (Page No. – 72)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 Rising prevalence of diabetes and favorable reimbursement policies in the country to drive the market growth
9.2.2 CANADA
9.2.2.1 Increasing government support to support market growth
9.3 EUROPE
9.3.1 UK
9.3.1.1 Increase in R&D activities to propel market growth in the UK
9.3.2 GERMANY
9.3.2.1 Increasing incidence of diabetes will boost the market growth in Germany
9.3.3 FRANCE
9.3.3.1 Rising geriatric population to drive the demand for advanced wound dressings in the country
9.3.4 ITALY
9.3.4.1 Unfavorable reimbursement scenario for wound dressings will hinder market growth in Italy
9.3.5 SPAIN
9.3.5.1 Rising geriatric population in the country to support market growth
9.3.6 RUSSIA
9.3.6.1 Government focus on increasing diabetes awareness will favor market growth in Russia
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 Increasing incidence of DFUs to support market growth in China
9.4.2 JAPAN
9.4.2.1 Favorable regulations in Japan have boosted product launch and commercialization activities
9.4.3 INDIA
9.4.3.1 High rate of SSIs and growing investments indicate strong opportunities for market growth
9.4.4 AUSTRALIA
9.4.4.1 Increasing initiatives to spread awareness on effective wound care to support market growth
9.4.5 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.1.1 Brazil is the largest market for healthcare in the Latin American region
9.5.2 MEXICO
9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico
9.5.3 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 RISING PREVALENCE OF DIABETES IN THIS REGION TO SUPPORT |THE MARKET GROWTH

10 COMPETITIVE LANDSCAPE (Page No. – 124)
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2019
10.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
10.4 VENDOR INCLUSION CRITERIA
10.5 VENDOR DIVE
10.5.1 VISIONARY LEADERS
10.5.2 INNOVATORS
10.5.3 DYNAMIC DIFFERENTIATORS
10.5.4 EMERGING COMPANIES
10.6 COMPETITIVE SCENARIO
10.6.1 PRODUCT LAUNCHES & APPROVALS
10.6.2 PARTNERSHIPS
10.6.3 ACQUISITIONS
10.6.4 EXPANSIONS

11 COMPANY PROFILES (Page No. – 130)
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 SMITH & NEPHEW PLC
11.2 MÖLNLYCKE HEALTH CARE AB
11.3 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
11.4 CONVATEC GROUP PLC
11.5 COLOPLAST A/S
11.6 3M
11.7 PAUL HARTMANN AG
11.8 B. BRAUN MELSUNGEN AG
11.9 CARDINAL HEALTH
11.10 ADVANCED MEDICAL SOLUTIONS GROUP PLC
11.11 MEDLINE INDUSTRIES, INC.
11.12 LOHMANN & RAUSCHER INTERNATIONAL GMBH & CO. KG
11.13 HOLLISTER INCORPORATED.
11.14 DEROYAL INDUSTRIES, INC.
11.15 ADVANCIS MEDICAL
11.16 URGO MEDICAL
11.17 DERMARITE INDUSTRIES, LLC
11.18 SHIELD LINE
11.19 WINNER MEDICAL CO., LTD.
11.20 ZENI MEDICAL